GlaxoSmithKline

GlaxoSmithKline logo
πŸ‡¬πŸ‡§United Kingdom
Ownership
Public
Established
1929-01-01
Employees
70.2K
Market Cap
$90B
Website
http://www.gsk.com
Introduction

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Phase 2
Completed
Conditions
First Posted Date
2005-07-19
Last Posted Date
2016-11-04
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
776
Registration Number
NCT00120848
Locations
πŸ‡¨πŸ‡¦

GSK Investigational Site, Toronto, Ontario, Canada

A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine

Phase 3
Terminated
Conditions
First Posted Date
2005-07-14
Last Posted Date
2017-03-23
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
5000
Registration Number
NCT00119743
Locations
πŸ‡ΈπŸ‡°

GSK Investigational Site, Zlate Moravce, Slovakia

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

Phase 1
Completed
Conditions
First Posted Date
2005-07-13
Last Posted Date
2008-10-16
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
30
Registration Number
NCT00119171
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, San Antonio, Texas, United States

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis

Phase 3
Completed
Conditions
First Posted Date
2005-07-12
Last Posted Date
2017-08-21
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
350
Registration Number
NCT00118703
Locations
πŸ‡·πŸ‡΄

GSK Investigational Site, Iasi, Romania

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

First Posted Date
2005-07-12
Last Posted Date
2016-09-23
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
227
Registration Number
NCT00118690
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Burke, Virginia, United States

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

First Posted Date
2005-07-12
Last Posted Date
2019-02-05
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
248
Registration Number
NCT00118716
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Milwaukee, Wisconsin, United States

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action

First Posted Date
2005-07-12
Last Posted Date
2016-09-15
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
380
Registration Number
NCT00118729
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Woodstock, Georgia, United States

Study Of Adults And Adolescents With Vasomotor Rhinitis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2005-07-06
Last Posted Date
2018-03-13
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
352
Registration Number
NCT00117325
Locations
πŸ‡·πŸ‡΄

GSK Investigational Site, Deva, Romania

A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults

First Posted Date
2005-07-01
Last Posted Date
2016-09-15
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
90
Registration Number
NCT00116818
Locations
πŸ‡¨πŸ‡¦

GSK Investigational Site, Mississauga, Ontario, Canada

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

First Posted Date
2005-07-01
Last Posted Date
2016-09-15
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
90
Registration Number
NCT00116883
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Richmond, Virginia, United States

Β© Copyright 2024. All Rights Reserved by MedPath